Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-017671
Filing Date
2022-05-11
Accepted
2022-05-11 18:01:44
Documents
1
Period of Report
2022-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 23770
  Complete submission text file 0000899243-22-017671.txt   25156
Mailing Address C/O COLUMN GROUP LP 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
GOEDDEL DAVID V (Reporting) CIK: 0001182464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 22915035

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations